Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets Surge for Absci NASDAQABSI on March 6 2024

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Finance_Commercial (2)
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Analyst Ratings and Price Targets for Absci (NASDAQ:ABSI) on March 6, 2024

Analysts have recently shared their sentiments towards Absci (NASDAQ:ABSI), offering a range of ratings that reflect varying perspectives on the company. Let’s take a look at the recent ratings and price targets:

Recent Ratings:
– Bullish: 2 analysts rated it as Bullish, with one also considering it Somewhat Bullish in the past month.
– Neutral: No analysts have provided an Indifferent rating recently.
– Bearish: There have been no recent Bearish or Somewhat Bearish ratings.

Price Targets:
Analysts’ 12-month price targets indicate an average target of $7.25, with a high estimate of $9.00 and a low estimate of $5.00. The current average price target has surged by 81.25% compared to the previous average of $4.00.

Key Analyst Actions and Insights:
Notable actions and adjustments have been made by analysts like Robyn Karnauskas, Scott Schoenhaus, and Swayampakula Ramakanth for Absci:
– Robyn Karnauskas announced a Buy rating with a price target of $9.00.
– Scott Schoenhaus upgraded the rating to Overweight with a new price target of $8.00, up from $5.00.
– Swayampakula Ramakanth also raised the rating to Buy with a fresh price target of $7.00, previously at $4.00.
– Scott Schoenhaus further increased the rating to Overweight with a price target of $5.00, up from $3.00.

Analysts’ actions reflect their responses to market dynamics and Absci’s performance, offering valuable insights into the company’s current position in the eyes of financial experts. For more detailed information on Absci’s stock analysis and analyst recommendations, you can refer to TipRanks, Benzinga, Yahoo Finance, Stock Analysis, and Nasdaq.

ABSI Stock Shows Strong Performance Near 52-Week High and Above 200-Day Moving Average

On March 6, 2024, ABSI stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend and is showing positive momentum.

The price of ABSI shares increased by $0.38 since the market last closed, representing a significant 7.22% rise. The stock opened at $5.70, which was $0.44 higher than its previous close. This opening price suggests that there was strong buying interest in ABSI at the start of the trading day.

Investors may be attracted to ABSI due to its strong price momentum and the fact that it is trading near its 52-week high. This could signal that the stock has potential for further growth in the near future. Additionally, being above its 200-day simple moving average indicates that the stock has been performing well over a longer period of time.

ABSI Stock Performance Analysis: Revenue and Net Income Fluctuations on March 6, 2024

On March 6, 2024, ABSI stock showed some interesting performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $5.75 million, which represented a 20.18% increase compared to the previous year. However, in the most recent quarter, total revenue dropped significantly to $744,000, marking a 77.9% decrease from the previous quarter. When it comes to net income, ABSI reported a loss of $104.90 million for the past year, which was a 3.91% decrease compared to the previous year. In the third quarter, the net income improved to -$21.99 million, showing a 47.22% increase from the previous quarter. Earnings per share (EPS) also saw some fluctuations during the same period. The EPS for the past year was -$1.15, which represented a 3.63% decrease compared to the previous year. In the third quarter, EPS improved to -$0.24, marking a 47.44% increase from the previous quarter. Overall, ABSI stock performances on March 6, 2024, reflected a mixed bag of results. Investors may want to closely monitor these financial metrics and company developments to make informed decisions about ABSI stock in the future.

Tags: ABSI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Trading online

Target Receives Market Perform Rating Upgrade and Increased Price Target

Food Retailers Market Capitalization

Analyst Confidence and Price Targets for Ross Stores NASDAQ ROST

Biotechnology Stock Market Today (1)

BiomX Soars with Merger and Funding Announcement

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com